The Enterprise Value as of December 2025 (TTM) for VistaGen Therapeutics, Inc. (VTGN) is 78.69M

According to VistaGen Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 78.69M. This represents a change of 182.75% compared to the average of 27.83M of the last 4 quarters.

VistaGen Therapeutics, Inc. (VTGN) Historical Enterprise Value (quarterly & annually)

How has VTGN Enterprise Value performed in the past?

The mean historical Enterprise Value of VistaGen Therapeutics, Inc. over the last ten years is 247.80M. The current 78.69M Enterprise Value has changed 3.08% with respect to the historical average. Over the past ten years (40 quarters), VTGN's Enterprise Value was at its highest in in the June 2021 quarter at 504.12M. The Enterprise Value was at its lowest in in the December 2023 quarter at -48754132.90.

VistaGen Therapeutics, Inc. (VTGN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of VistaGen Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

VistaGen Therapeutics, Inc. (VTGN) Average Enterprise Value

How has VTGN Enterprise Value performed in the past?

The current Enterprise Value of VistaGen Therapeutics, Inc. (VTGN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

VistaGen Therapeutics, Inc. (VTGN) Enterprise Value vs. Peers

How is VTGN’s Enterprise Value compared to its peers?

VistaGen Therapeutics, Inc.’s Enterprise Value is less than Spero Therapeutics, Inc. (83.18M), less than Seer, Inc. (86.40M), less than Seres Therapeutics, Inc. (194.69M), less than Opus Genetics, Inc. (121.30M), less than Cognition Therapeutics, Inc. (119.19M), less than TuHURA Biosciences, Inc. (92.82M), less than Agenus Inc. (181.50M), less than Actuate Therapeutics Inc (153.91M), greater than Acumen Pharmaceuticals, Inc. (76.70M), less than Inovio Pharmaceuticals, Inc. (94.56M),

Build a custom stock screener for VistaGen Therapeutics, Inc. (VTGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like VistaGen Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

VistaGen Therapeutics, Inc. (VTGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like VistaGen Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.